Works matching AU Linfeng Li


Results: 245
    1
    2
    3
    4
    5
    6
    7
    8
    9
    10
    11
    12

    Sublingual immunotherapy of atopic dermatitis in mite-sensitized patients: a multi-centre, randomized, double-blind, placebo-controlled study.

    Published in:
    Artificial Cells, Nanomedicine & Biotechnology, 2019, v. 47, n. 1, p. 3540, doi. 10.1080/21691401.2019.1640709
    By:
    • Liu, Lunfei;
    • Chen, Jisu;
    • Xu, Jinhua;
    • Yang, Qinping;
    • Gu, Chaoying;
    • Ni, Chunya;
    • Li, Linfeng;
    • Lu, Xueyan;
    • Yao, Zhirong;
    • Tao, Jianfeng;
    • Guo, Yifeng;
    • Fang, Hong;
    • Ding, Yingguo;
    • Qian, Qihong;
    • Zhou, Naihui;
    • Wang, Miaomiao;
    • Deng, Danqi;
    • Xie, Hong;
    • Li, Shenqiu;
    • Huang, Yongchu
    Publication type:
    Article
    13
    14
    15
    16

    Effect of postprocedural full-dose infusion of bivalirudin on acute stent thrombosis in patients with ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention: Outcomes in a large real-world population.

    Published in:
    Cardiovascular Therapeutics, 2017, v. 35, n. 3, p. n/a, doi. 10.1111/1755-5922.12251
    By:
    • Wang, Heyang;
    • Liang, Zhenyang;
    • Li, Yi;
    • Li, Bin;
    • Liu, Junming;
    • Hong, Xueyi;
    • Lu, Xin;
    • Wu, Jiansheng;
    • Zhao, Wei;
    • Liu, Qiang;
    • An, Jian;
    • Li, Linfeng;
    • Pu, Fanli;
    • Ming, Qiang;
    • Han, Yaling
    Publication type:
    Article
    17
    18

    Efficacy and safety of topical minocycline foam (FMX101 4%) in treatment of Chinese subjects with moderate‐to‐severe facial acne vulgaris: A phase 3, multi‐centre, randomized, double‐blind, vehicle‐controlled study.

    Published in:
    Journal of the European Academy of Dermatology & Venereology, 2025, v. 39, n. 5, p. 967, doi. 10.1111/jdv.20159
    By:
    • Le, Yan;
    • Yang, Wenlin;
    • Lu, Jianyun;
    • Jiang, Xian;
    • Guo, Qing;
    • Huang, Chunyun;
    • Sun, Qing;
    • Wang, Huiping;
    • Bi, Mingye;
    • Wang, Haiying;
    • Geng, Songmei;
    • Yang, Bin;
    • Xu, Ai‐E;
    • Cui, Yong;
    • Man, Xiaoyong;
    • Zhao, Yi;
    • Zhang, Litao;
    • Li, Linfeng;
    • Song, Zhiqiang;
    • Chen, Jin
    Publication type:
    Article
    19

    Efficacy and Safety of HLX03, an Adalimumab Biosimilar, in Patients with Moderate-to-Severe Plaque Psoriasis: A Randomized, Double-Blind, Phase III Study.

    Published in:
    Advances in Therapy, 2022, v. 39, n. 1, p. 583, doi. 10.1007/s12325-021-01899-0
    By:
    • Cai, Lin;
    • Li, Linfeng;
    • Cheng, Hao;
    • Ding, Yangfeng;
    • Biao, Zhenshu;
    • Zhang, Shifa;
    • Geng, Songmei;
    • Liu, Quanzhong;
    • Fang, Hong;
    • Song, Zhiqi;
    • Lu, Yan;
    • Li, Shanshan;
    • Guo, Qing;
    • Tao, Juan;
    • He, Li;
    • Gu, Jun;
    • Yang, Qinping;
    • Han, Xiuping;
    • Gao, Xinghua;
    • Deng, Danqi
    Publication type:
    Article
    20
    21
    22
    23
    24
    25
    26
    27
    28
    29
    30
    31
    32
    33
    34
    35
    36
    37
    38
    39
    40
    41
    42
    43
    44
    45
    46
    47
    48
    49
    50